BanderasNews
Puerto Vallarta Weather Report
Welcome to Puerto Vallarta's liveliest website!
Contact UsSearch
Why Vallarta?Vallarta WeddingsRestaurantsWeatherPhoto GalleriesToday's EventsMaps
 NEWS/HOME
 EDITORIALS
 ENTERTAINMENT
 VALLARTA LIVING
 PV REAL ESTATE
 TRAVEL / OUTDOORS
 HEALTH / BEAUTY
 SALON & SPA SERVICES
 HEALTH FOR WOMEN
 HEALTH FOR MEN
 YOUR WELL BEING
 THE CHALLENGE CORNER
 DENTAL HEALTH
 ON ADDICTION
 RESOURCES
 SPORTS
 DAZED & CONFUSED
 PHOTOGRAPHY
 CLASSIFIEDS
 READERS CORNER
 BANDERAS NEWS TEAM
Sign up NOW!

Free Newsletter!

Puerto Vallarta News NetworkHealth & Beauty | August 2008 

Merck To Sell Discounted Antiretrovirals To Mexico
email this pageprint this pageemail usMedicalNewsToday


 
Mexican Health Secretary Jose Angel Cordova said drugmaker Merck has agreed to sell two antiretroviral drugs at a reduced price in Mexico, the AP/International Herald Tribune reports.

Cordova said that Merck will sell Stocrin, a first-line antiretroviral, and Isentress, a newer antiretroviral, at discounts of up to 40%. Cordova added that about 22,000 HIV-positive people in the country being treated by the Public Health Department take Stocrin and about 200 take Isentress (AP/International Herald Tribune, 8/1).

At a recent meeting with officials representing 50 humanitarian organizations, Mexican President Felipe Calderon announced that the country was in talks with the pharmaceutical industry to cut the cost of antiretrovirals. Calderon also said he would establish a commission to help negotiate the price of drugs and work to achieve fairer prices to help HIV-positive people receive treatment.

According to Prensa Latina, antiretrovirals are four times more expensive in Mexico than in other countries with comparable incomes (Prensa Latina, 7/30).

The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation.



In accordance with Title 17 U.S.C. Section 107, this material is distributed without profit to those who have expressed a prior interest in receiving
the included information for research and educational purposes • m3 © 2008 BanderasNews ® all rights reserved • carpe aestus